Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Erfonrilimab by Alphamab Oncology for Metastatic Hepatocellular Carcinoma (HCC): Likelihood of Approval
Erfonrilimab is under clinical development by Alphamab Oncology and currently in Phase II for Metastatic Hepatocellular Carcinoma (HCC). According to...
Envafolimab by Alphamab Oncology for Cutaneous Squamous Cell Carcinoma (cSCC): Likelihood of Approval
Envafolimab is under clinical development by Alphamab Oncology and currently in Phase II for Cutaneous Squamous Cell Carcinoma (cSCC). According...
Erfonrilimab by Alphamab Oncology for Kidney Cancer (Renal Cell Cancer): Likelihood of Approval
Erfonrilimab is under clinical development by Alphamab Oncology and currently in Phase I for Kidney Cancer (Renal Cell Cancer). According...
Erfonrilimab by Alphamab Oncology for Small-Cell Lung Cancer: Likelihood of Approval
Erfonrilimab is under clinical development by Alphamab Oncology and currently in Phase I for Small-Cell Lung Cancer. According to GlobalData,...
Envafolimab by Alphamab Oncology for Merkel Cell Carcinoma: Likelihood of Approval
Envafolimab is under clinical development by Alphamab Oncology and currently in Phase II for Merkel Cell Carcinoma. According to GlobalData,...
Envafolimab by Alphamab Oncology for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
Envafolimab is under clinical development by Alphamab Oncology and currently in Phase II for Head And Neck Squamous Cell Carcinoma...
Envafolimab by Alphamab Oncology for Papillary Thyroid Cancer: Likelihood of Approval
Envafolimab is under clinical development by Alphamab Oncology and currently in Phase II for Papillary Thyroid Cancer. According to GlobalData,...
Envafolimab by Alphamab Oncology for Follicular Thyroid Cancer: Likelihood of Approval
Envafolimab is under clinical development by Alphamab Oncology and currently in Phase II for Follicular Thyroid Cancer. According to GlobalData,...
Envafolimab by Alphamab Oncology for Neuroendocrine Tumors: Likelihood of Approval
Envafolimab is under clinical development by Alphamab Oncology and currently in Phase II for Neuroendocrine Tumors. According to GlobalData, Phase...
Envafolimab by Alphamab Oncology for Vulvar Cancer: Likelihood of Approval
Envafolimab is under clinical development by Alphamab Oncology and currently in Phase II for Vulvar Cancer. According to GlobalData, Phase...
Envafolimab by Alphamab Oncology for Salivary Gland Cancer: Likelihood of Approval
Envafolimab is under clinical development by Alphamab Oncology and currently in Phase II for Salivary Gland Cancer. According to GlobalData,...
Envafolimab by Alphamab Oncology for Solid Tumor: Likelihood of Approval
Envafolimab is under clinical development by Alphamab Oncology and currently in Phase II for Solid Tumor. According to GlobalData, Phase...
Envafolimab by Alphamab Oncology for Small-Cell Lung Cancer: Likelihood of Approval
Envafolimab is under clinical development by Alphamab Oncology and currently in Phase II for Small-Cell Lung Cancer. According to GlobalData,...
Envafolimab by Alphamab Oncology for Sepsis: Likelihood of Approval
Envafolimab is under clinical development by Alphamab Oncology and currently in Phase I for Sepsis. According to GlobalData, Phase I...
Envafolimab by Alphamab Oncology for Melanoma: Likelihood of Approval
Envafolimab is under clinical development by Alphamab Oncology and currently in Phase II for Melanoma. According to GlobalData, Phase II...
Envafolimab by Alphamab Oncology for Colorectal Cancer: Likelihood of Approval
Envafolimab is under clinical development by Alphamab Oncology and currently in Phase II for Colorectal Cancer. According to GlobalData, Phase...
Envafolimab by Alphamab Oncology for Ovarian Cancer: Likelihood of Approval
Envafolimab is under clinical development by Alphamab Oncology and currently in Phase II for Ovarian Cancer. According to GlobalData, Phase...
Erfonrilimab by Alphamab Oncology for Gastroesophageal (GE) Junction Carcinomas: Likelihood of Approval
Erfonrilimab is under clinical development by Alphamab Oncology and currently in Phase II for Gastroesophageal (GE) Junction Carcinomas. According to...
Erfonrilimab by Alphamab Oncology for Gastric Cancer: Likelihood of Approval
Erfonrilimab is under clinical development by Alphamab Oncology and currently in Phase II for Gastric Cancer. According to GlobalData, Phase...
JSKN-003 by Alphamab Oncology for Ovarian Cancer: Likelihood of Approval
JSKN-003 is under clinical development by Alphamab Oncology and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase...